Publications by authors named "Sho Otake"

Claim this Profile
S
Suppressive Effects of JTE-151, a Novel Orally Available RORγ Antagonist, in Experimental Models of Rheumatoid Arthritis.
Kojo Arita, Sho Otake, Kazuma Kobayashi, Hidenori Iwasaki, Yoshihisa Okamoto

Biol Pharm Bull· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological Properties of JTE-151; A Novel Orally Available RORγ Antagonist That Suppresses Th17 Cell-Related Responses and .
Kojo Arita, Haiyan Tao, Paul Crowe, Scott Thacher, Sho Otake

Biol Pharm Bull· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical Application of BMS-509744, a Selective Inhibitor of Interleukin-2-Inducible T Cell Kinase, Ameliorates Imiquimod-Induced Skin Inflammation in Mice.
Sho Otake, Tomoko Otsubaki, Naofumi Uesato, Yoshifumi Ueda, Toshihiko Murayama

Biol Pharm Bull· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular density-dependent down-regulation of EP4 prostanoid receptors via the up-regulation of hypoxia-inducible factor-1α in HCA-7 human colon cancer cells.
Sho Otake, Kenji Yoshida, Naofumi Seira, Christopher M Sanchez, John W Regan

Pharmacol Res Perspect· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of the expression and activity of glucose and lactic acid metabolism-related genes by protein kinase C in skeletal muscle cells.
Sho Otake, Masaki Kobayashi, Katsuya Narumi, Shotaro Sasaki, Yurika Kikutani

Biol Pharm Bull· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of cyclooxygenase-2 expression by prostaglandin E2 stimulation of the prostanoid EP4 receptor via coupling to Gαi and transactivation of the epidermal growth factor receptor in HCA-7 human colon cancer cells.
Kenji Yoshida, Hiromichi Fujino, Sho Otake, Naofumi Seira, John W Regan

Eur J Pharmacol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contrary effects of sphingosine-1-phosphate on expression of α-smooth muscle actin in transforming growth factor β1-stimulated lung fibroblasts.
Tatsuo Kawashima, Risa Yamazaki, Yasuo Matsuzawa, Erika Yamaura, Mamoru Takabatake, Sho Otake

Eur J Pharmacol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of human monocarboxylate transporter 4 in skeletal muscle cells: the role of protein kinase C (PKC).
Katsuya Narumi, Masaki Kobayashi, Sho Otake, Ayako Furugen, Natsuko Takahashi

Int J Pharm· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indomethacin antagonizes EP(2) prostanoid receptor activation in LS174T human colon cancer cells.
Yuta Ikawa, Hiromichi Fujino, Sho Otake, Toshihiko Murayama

Eur J Pharmacol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of monocarboxylate transporter 1 in skeletal muscle cells by intracellular signaling pathways.
Katsuya Narumi, Ayako Furugen, Masaki Kobayashi, Sho Otake, Shirou Itagaki

Biol Pharm Bull· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AMP-activated protein kinase regulates the expression of monocarboxylate transporter 4 in skeletal muscle.
Ayako Furugen, Masaki Kobayashi, Katsuya Narumi, Meguho Watanabe, Sho Otake

Life Sci· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis